pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 22·1 min read
save

AbbVie's $1.4B North Carolina manufacturing site to finish during Trump's term

AbbVie has provided new details about its $100 billion pledge to the US, budgeting $1.4 billion for its first manufacturing campus in North Carolina. Construction of the 185-acre campus in Durham, NC, will start this ...

Apr 22, 2026·read at Endpoints ↗

Image rendering of AbbVie's Durham, NC, campus (Credit: AbbVie) April 22, 2026 02:38 PM EDTUpdated April 23, 06:24 AM PharmaManufacturing Ab­b­Vie's $1.4B North Car­oli­na man­u­fac­tur­ing site to fin­ish dur­ing Trump's term Anna Brown News Reporter Ab­b­Vie has pro­vid­ed new de­tails about its $100 bil­lion pledge to the US, bud­get­ing $1.4 bil­lion for its first man­u­fac­tur­ing cam­pus in North Car­oli­na. Con­struc­tion … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
95 words · retrieved Apr 26
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ABBVIE4

related stories

  • Jul 14Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pillBioPharma Dive
  • Jul 10ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadershipBioPharma Dive
  • Jul 9GSK ends brain drug alliance with AlectorBioPharma Dive
  • Jul 6Apogee details path to $10.9B AbbVie deal; UK starts drug pricing pilotEndpoints
  • Jul 6Novartis to acquire ADC developer in a deal worth up to $1.5BBioPharma Dive